Disclosure: The survey and the expert panel that form the basis of this manuscript were sponsored by Hospira, Inc. (Lake Forest, IL, USA), which was acquired by Pfizer in September 2015. All six authors were members of a speakers' bureau funded by Hospira. The authors received no compensation toward the development and writing of this manuscript.
Introduction
Despite advances in our understanding of pain pathways and the development of novel analgesic options, many surgical patients suffer from inadequately managed postoperative pain [1] [2] [3] [4] [5] . Effective pain management represents an important priority for surgical patients and their physicians, as reflected by recognition of pain as the "fifth vital sign" [6, 7] . Opioids are routinely used to manage surgical pain [8] [9] [10] ; however, the risks of opioid-related adverse events (ORADEs) and their negative impact on patients, health systems, and health care costs have been widely reported [11] [12] [13] [14] . Possible ORADEs in the postoperative setting include gastrointestinal effects, respiratory complications, and complications related to central nervous system function [10, 12, [15] [16] [17] [18] [19] [20] . Further, opioid use may result in acute tolerance, increase morbidity, and present risks of iatrogenic (induced by medical treatment) addiction, even when they are prescribed and used appropriately [11, 13, 14, 21, 22] .
In the past two decades, significant increases in opioid prescriptions for both chronic and acute pain have been observed in the United States [23] [24] [25] . Strikingly, Americans make up less than 5% of the world's population but consume approximately 80% of the world's opioid supply [26, 27] . There is mounting concern that opioids are overused in the United States [26] , with the term "opioid epidemic" frequently used to emphasize the urgency of the situation. In contrast, European opioid prescribing practices are typically conservative, and legal and regulatory barriers may limit the accessibility of opioids in European countries [28] [29] [30] . It is therefore not surprising that per capita morphine consumption in the United States greatly exceeds that in European countries [31] , and also noteworthy is that opioid accessibility restrictions are regarded as excessive by some European medical professionals and considered a potential reason for inadequate pain relief in the European population [28] .
Acknowledging the critical concerns related to opioid use, there is growing emphasis on the use of combinations of opioid-and nonopioid analgesics as part of a multimodal approach to postoperative pain management. Multimodal perioperative management practices that limit reliance on opioids have been gaining wide acceptance in Europe; however, such approaches have only recently begun to be implemented in some US institutions [32] [33] [34] [35] . Multimodal regimens can improve postoperative analgesia and reduce opioid consumption in the postoperative period, thereby minimizing the adverse effects that can slow recovery following surgery [9, 17, 18, 21, [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] . The American Society of Anesthesiologists endorses multimodal approaches that include the use of nonsteroidal anti-inflammatory drugs (NSAIDs; both nonselective and COX-2-selective), acetaminophen, and local anesthetics, in addition to opioids, for management of acute postoperative pain [47] .
Given the importance of defining best perioperative pain management practices based on current evidence, a clinical appraisal regarding opioid use in the surgical setting was conducted to evaluate the validity of the statement "Opioids are not overused in the United States, even though opioid adjunct therapy achieves greater pain control with less risk" as it relates to perioperative medicine. The appraisal consisted of three parts: 1) a national survey to understand current US physician perspectives regarding opioid administration; 2) a review of the current literature related to opioid prescribing in the surgical setting; and 3) a meeting of the authors to assess the evidence and its implications for perioperative medicine and to identify clinical research that will enable improved outcomes.
Methodology

National Survey
Prior to the clinical appraisal meeting, an electronic survey was distributed to 70,000 members of the American Medical Association. Institutional review board exemption was granted by The Ohio State University College of Medicine Institutional Review Board. The survey sought to understand physician opinions on a number of distinct but related issues regarding pain management that are the subject of current debate in the medical community. The survey was distributed by email on June 10, 2015, with responses accepted through July 10, 2015. Physicians involved in surgical pain management (anesthesiologists, general surgeons, orthopedic surgeons) were asked to indicate their level of agreement (1 ¼ strongly agree; 2 ¼ mostly agree, but with minor reservations; 3 ¼ slightly agree, but with major reservations; 4 ¼ slightly disagree, due to minor reservations; 5 ¼ mostly disagree, due to major reservations; 6 ¼ strongly disagree) with each survey statement. Respondents also had the opportunity to provide written comments regarding each statement. For the statement that is the subject of this report, a total of 566 national survey responses were analyzed (311, 54.9%, anesthesiologists, 180, 31.8%, general surgeons, 75, 13.3%, orthopedic surgeons). Results were tabulated and stratified by clinical specialty.
Expert Panel and Literature Review
The statement "Opioids are not overused in the United States, even though opioid adjunct therapy achieves greater pain control with less risk" was evaluated during a July 2015 meeting of the authors. The first author was tasked with the presentation of an unbiased review of the current literature pertaining to this statement, presenting both statement-supporting evidence and statement-refuting publications. The purpose of the meeting was to undertake a balanced and unbiased discussion of the evidence, with a focus on evaluating the validity of this statement as it applies to perioperative medicine. The authors also assessed how the evidence relates to current perceptions, as demonstrated by the national survey results.
A literature search was performed in June 2015 using the Cochrane Database with the search term "postoperative pain."
After initial review, a total of 17 articles were identified as being relevant based on external/internal validity criteria (study population, clinical similarities).
Two articles (McNicol et al. 2015 [48] and Moore et al. 2011 [49] ) were included in the presentation to the author panel as these two studies constituted high-quality meta-analyses evaluating the use of different opioid regimens in postoperative settings.
Two additional sources (Joshi et al. 2014 [50] and Panchal 2011 [51] ) were selected based on the presenter's experience as a co-author and clinician dedicated "to rais[ing] awareness and develop[ing] best practice guidelines for improving surgical pain management" [50] .
An audit analyzing the gap of analgesia in the postoperative period, conducted by Ng et al. 2000 [52] , was included for review and discussion.
Prior to presentation of the selected studies, the authors anonymously indicated their level of agreement with the appraisal statement using the same six-point scale provided to national survey respondents. Following presentation of the evidence, the authors rated the quality of the evidence according to the following criteria: 1 ¼ evidence obtained from meta-analysis, including at least one large, randomized controlled trial (RCT); 2 ¼ evidence obtained from either meta-analysis, including at least one small RCT, or from at least one well-designed large RCT; 3 ¼ evidence obtained from well-designed cohort or case-controlled studies; 4 ¼ evidence obtained from case series, case reports, or flawed clinical trials; 5 ¼ opinions of respected authorities based on clinical experience, descriptive studies, or reports of expert committees; 6 ¼ insufficient evidence to form an opinion. Following presentation of the literature, the authors indicated their level of agreement with the appraisal statement a second time, noting whether the presented evidence affected their assessment. The authors discussed how the evidence related to current perioperative pain management practice and identified future needs.
Survey Results and Literature Review
Survey Results
The national survey demonstrated considerable variability in the level of support for the statement "Opioids are not overused in the United States, even though opioid adjunct therapy achieves greater pain control with less risk" among the respondent physicians (Figure 1 ), reflecting the complexity of current thinking on this issue. Respondents expressed a range of opinions that included all six levels of support for the statement, though the majority (62% of anesthesiologists, 62% of general surgeons, and 75% of orthopedic surgeons) expressed some level of disagreement with the statement. Overall, the mean level of support across all national survey respondents, using the 1-6 scale, was 3.99, and therefore trended toward disagreement with the statement. Based on the respondents' comments, disagreement tended to be primarily related to the first part of the statement. One commonly expressed opinion was that overuse of opioids for pain management was common and that appropriate management of patient expectations was a major unmet need. Responses also indicated a perception among the surveyed physicians that opioids are frequently misused for chronic pain and that a lack of knowledge regarding alternative options might contribute to opioid overuse/abuse. Following a trend similar to that observed in the national survey, the prepresentation panel survey resulted in four of the six authors expressing mostly disagreement due to major reservations, while two of the six authors expressed agreement with some reservations (Figure 2 ).
Literature Review: Safety and Efficacy of Opioids in the Perioperative Setting
Two recent meta-analyses examining opioid use for acute postsurgical pain were reviewed. McNicol et al. [48] evaluated the safety and efficacy of patientcontrolled IV opioid analgesia (PCA) vs non-PCA (conventional opioid regimens such as IV bolus or infusion, intramuscular (IM), and subcutaneous delivery) in the postoperative setting. The systematic review and metaanalysis included 49 RCTs with 1,725 participants receiving PCA and 1,687 patients in the non-PCA group. The review included RCTs assessing pain as a primary or secondary outcome in studies that were more than three years old, examined outcomes in chronic pain patients, or had fewer than 10 participants per arm excluded. The meta-analysis encompassed patients undergoing different types of surgery, including lower or upper abdominal, cardiothoracic, and neurological surgery. The analysis revealed significantly lower pain scores (on the 0-100 mm visual analog scale [VAS]) for patients receiving PCA vs non-PCA. The mean difference on the VAS for PCA vs non-PCA was -8.82 (95% confidence interval [CI] ¼ -13.09 to -4.54) for 0-24 hours postsurgery and -9.74 (95% CI ¼ -12.59 to -6.99) for 0-48 hours postsurgery. In addition to lower pain scores, the authors identified greater patient satisfaction (81% vs 61%; P ¼ 0.002) for patients in the PCA group. Conversely, the mean difference of opioid consumption for patients in the PCA group vs non-PCA was 7.21 (95% CI ¼ 1.44 to 12.98), and the PCA group also had a higher incidence of pruritus (15% vs 8%; P ¼ 0.01) compared with non-PCA. No differences in hospital length of stay or incidence of other adverse events were identified. Overall, these results demonstrated that opioids may be used to control by NSAIDs, then it would be highly beneficial for pain management with orthopedic procedures" both prior to and following presentation of the evidence discussed in this review. Mean level of support, using the 1-6 scale, was 4.17 both prior to and following the presentation.
postoperative pain effectively and that PCA with opioids is at least as efficacious as non-PCA regimens.
Moore et al. 2012 [49] offered "reliable evidence" of oral analgesics intervention for postoperative acute pain in dental procedures (29,000) and nondental conditions (episiotomy, orthopedic, and abdominal surgeries) when study participants have "at least moderate pain" in order to offer a "sensitive pain-relieving" assessment.
The authors evaluated data from 35 Cochrane Reviews (45,000 participants from 350 studies). Overall, the review examined 46 drug/dose combinations primarily in the dental pain setting, but also for nondental acute postoperative pain. Efficacy outcomes included number needed to treat (NNT) for greater than or equal to 50% pain relief over four to six hours, percentage of participants achieving at least 50% maximum pain relief, and duration of analgesia. For the analgesics included in the study, the selective COX-2 inhibitor etoricoxib 120 mg (NNT ¼ 1.9, 95% CI ¼ 1.7 to 2.1), codeine 60 mg plus acetaminophen 1,000 mg (NNT ¼ 2.2, 95% CI ¼ 1.8 to 2.9), and the NSAIDs ibuprofen 400 mg (NNT ¼ 2.5, 95% CI ¼ 2.4 to 2.6) and diclofenac 50 mg (NNT ¼ 2.7, 95% CI ¼ 2.4 to 3.0) were among the drugs with the lowest NNTs. No opioids were among the drug/dose combinations with the lowest NNTs, and opioid plus nonopioid combinations demonstrated greater efficacy than opioids alone. For example, a combination of codeine 60 mg and acetaminophen 800/1,000 mg resulted in an NNT of 2.2 (95% CI ¼ 1.8 to 2.9), while codeine 60 mg alone resulted in an NNT of 12 (95% CI ¼ 8.4 to 18). Similarly, opioid plus nonopioid combinations demonstrated longer durations of action than opioids alone. Mean time to remedication (MTR) was five hours with codeine 60 mg plus acetaminophen 800/1,000 mg, in comparison with 2.7 hours with codeine 60 mg alone, while MTR with oxycodone 5 mg plus acetaminophen 325 mg was 4.3 hours, in comparison with 2.3 hours for oxycodone 5 mg alone. In summary, this review provided evidence that when considering single oral doses following mainly dental procedures, opioid analgesia is improved when used in combination with nonopioids. It also supports the concept of multimodal analgesia rather than only opioid analgesia.
Literature Review: Current Perioperative Regimens and Challenges Associated with Opioid Use
To explore the use of opioids in the perioperative setting, the presented literature included a recent consensus article by Joshi et al. [50] that evaluated the current surgical pain management paradigm and identified key aspects of best pain management practices. Successful postoperative analgesia is vitally important as pain continues to be identified as a leading cause of hospital readmissions and patient dissatisfaction [53, 54] . Joshi et al. [50] note that in addition to the well-known shortterm consequences of inadequately managed acute postoperative pain, potentially severe long-term consequences, including development of chronic postoperative pain, can also result from poor acute pain management. Surgeries including amputation, coronary artery bypass, and thoracotomy have been associated with especially high incidences of chronic postoperative pain (30-50% of patients) and chronic severe disabling pain (5-10%) [55] , indicating the importance of determining procedures where adjuncts could be used to adequately control acute pain. According to Joshi et al. [50] , opioid intake should be minimized, but complete elimination of opioids in the postsurgical setting would be impractical and inappropriate. Instead, implementation of multimodal analgesia and procedure-and population-specific pain management regimens should be emphasized. Supporting this notion, a more recent study revealed improved pain scores with implementation of multimodal procedure-specific analgesic regimens [56] .
In order to investigate the effect of pain management regimens on analgesic gaps, Ng et al. [52] examined 89 patients who received either epidural or IV opioids following gynecological, general abdominal, orthopedic, vascular, general nonabdominal, urological, or maxillofacial surgery. The analgesic gap was defined as increased pain (VAS score increased by 50% or more) during the basic analgesic support (provision of acute pain relief) period following discontinuation of advanced analgesic support (epidural analgesia or IV opioids). The study reported analgesic gaps for 16%, 20%, and 9% of patients receiving one of the opioid regimens examined on days 0, 1, and 2, respectively. The authors noted that 17 of the 22 (77%) patients experiencing an analgesic gap on the day of discontinuation of the analgesic pump had their pump withdrawn too early (within 48 hours). Notably, the majority of patients received NSAIDs, paracetamol, and other analgesics, but no oral opioids, as part of their basic analgesic regimen, and the authors suggested that use of oral opioids up until 24 hours after the return of gastric motility may potentially bridge analgesic gaps. These findings imply that opioid use strategies might be improved in order to minimize analgesic gaps, and the authors indicated support for regular and continued use of advanced analgesic support for patients with continued high pain intensity instead of a premature transition to as-needed analgesia.
Finally, in a review of the advantages and drawbacks of different pain management delivery systems and therapies used in the hospital setting, Panchal [51] evaluated analgesic gaps (defined by the authors as periods during which the patient does not have access to analgesia) and described approaches to minimize their effects. Importantly, nonopioids can be used preemptively in an around-the-clock manner, and therefore help to minimize the occurrence of analgesic gaps. This type of approach is in accordance with the World Health Organization pain ladder, which indicates that pain should be treated with nonopioids such as acetaminophen, NSAIDs, and local and regional anesthesia when possible [57] . Though the review cautions that opioids may in some cases be associated with serious adverse effects, the author recommends the use of equianalgesic conversions and appropriate analgesic delivery systems to minimize analgesic gaps, noting that complex or multistep delivery systems may be prone to higher likelihood of technology failure or system-related events that may result in unintentional breaks in analgesia. Finally, Panchal suggests that the timing of the withdrawal of advanced analgesic support (such as IV or epidural therapy) should match the onset of action of the adjunct therapy, and that this precise timing is critical to avoid analgesic gaps and achieve appropriate pain control.
Quality and Impact of Evidence
Overall, three of the six authors assessed the presented evidence to be of high quality (level 2-evidence from a meta-analysis or RCTs), while two of the six and one of the six authors indicated that the strength of the evidence corresponded to level 3 (evidence from welldesigned cohort or case-control studies) and level 5 (opinion of respected authorities), respectively. Similar to the prepresentation survey, the postpresentation author survey revealed a tendency to disagree with the statement "Opioids are not overused in the United States, even though opioid adjunct therapy achieves greater pain control with less risk." Overall, three of the six authors expressed mostly disagreement due to major reservations, while one of the six indicated slight disagreement due to minor reservations, and two of the six indicated slight agreement with major reservations (Figure 2 ). The mean level of support for the statement, on the 1-6 scale, remained unchanged (4.17; trending towards disagreement) in comparison with the prepresentation survey.
Discussion
Recent trends have raised concerns that opioids are overused in the United States. Given the known risks associated with opioid use and misuse, close examination of opioid prescription habits across clinical areas is warranted. It is worthwhile for practitioners to lead legislators in attenuating the opioid crisis. Opioids have long represented a core component of postoperative analgesia regimens; however, there is growing support for multimodal strategies that also employ analgesics with different mechanisms and sites of action [35, 47, 58] . Emerging evidence demonstrating improved outcomes associated with perioperative practices that reduce opioid use [35, 59, 60] reinforces the importance of optimizing perioperative analgesia, and this clinical appraisal was focused on examining opioid use in the perioperative setting.
Evolving perspectives on opioids, as well as contrasting regulatory and legal dynamics, have important impacts on opioid use, as reflected by varying practices worldwide. The average morphine consumption in the United
States is nearly eight times that of European countries [31] , with contributing factors including regulatory measures in European countries that limit opioid availability [28] [29] [30] 35] , differing attitudes of European patients and physicians toward opioid use compared with their US counterparts, and the more limited availability (and higher costs) of NSAIDs in the United States. Surgical patients in the United States frequently receive opioids to control their pain, whereas physicians in European countries tend to take a more conservative approach to opioid prescription overall [28] [29] [30] . Multifaceted approaches to perioperative patient management that include preemptive multimodal analgesia and reduced reliance on opioids have been in place in European institutions for several years, only recent gaining adoption in some US institutions [32] [33] [34] . These enhanced recovery protocols are associated with more favorable outcomes following surgery, illustrating the benefits of approaches that use analgesics, including opioids, in a more strategic manner [33, 35, 59] .
Although it is clear that overall opioid use is high in the United States [27, 61] , the current literature does not irrefutably validate or invalidate the statement "Opioids are not overused in the United States, even though opioid adjunct therapy achieves greater pain control with less risk" as it relates to perioperative practice. Instead, review of the current literature suggests that the primary issue with respect to surgical pain management might not be curbing opioid overuse, but rather ensuring appropriate use. Ultimately, the challenge exists in controlling pain while reducing the risk for adverse effects related to any analgesic drug class, whether opioids, NSAIDs, or other nonopioids. The key is to ensure that opioids, like all other drugs, are used strategically in order to maximize treatment efficacy and safety ( Figure 3 ). The path forward should therefore be focused on improving procedure-and patient-specific multimodal analgesia in order to optimize pain relief and promote mobilization and favorable postoperative outcomes, including patient satisfaction.
Identifying surgical procedures and patient populations that present particular challenges with respect to pain management is critical to improving perioperative decision-making. While preemptive administration of opioids (in the absence of symptoms) is not optimal [62, 63] and opioids are associated with known risk adverse events, it is clear that opioids should not be eliminated from postoperative pain management regimens. Instead, the focus should be on strategic use (e.g., for breakthrough pain) and improved shared decisionmaking between patients and physicians based on available options and expectations once all other options have been exhausted [26, [64] [65] [66] [67] [68] . In addition to improving pain relief and patient safety, reducing the occurrence of analgesic gaps is a key consideration [69] that should be addressed via strategies that optimize the timing and withdrawal of opioid use and make use of nonopioid preemptive analgesia regimens.
The literature review and panel discussion summarized here emphasized opioid administration in the context of acute postsurgical pain. The observed range of responses in the national survey, in addition to being indicative of different perspectives on this important issue, may also reflect variation in the interpretation of the statement on the part of respondents (for example, emphasizing either the first or second part of the statement, considering the statement in the context of acute pain, chronic pain, or both). While not the subject of this appraisal, it is notable that overuse/abuse of opioids for chronic pain was widely acknowledged in both the national survey and by the authors. There is growing consensus and evidence that different types of pain require unique pain management strategies, and additional clarity regarding optimal approaches and the role of opioids in various settings remains an important ongoing need in the pain management field.
Consensus Statement
In the context of the perioperative setting, the current literature does not provide unequivocal evidence for or against the statement that "Opioids are not overused in the United States, even though opioid adjunct therapy achieves greater pain control with less risk." It is evident, however, that strategic administration of opioids in combination with other analgesics represents an important opportunity to support improved postoperative outcomes and reduce the frequency and severity of opioid-related adverse events. Known differences in pain management practices between the United States and Europe provide a basis for evaluating the impact of different analgesia strategies on patient satisfaction and outcomes, with the goal of identifying personalized pain management algorithms that maximize recovery while minimizing safety risks. Growing emphasis on more patient-centered multimodal pain management regimens brings to attention the need for comprehensive studies examining the benefits of different approaches to opioid use in relation to key patient-and procedure-related factors.
6 Elvir-Lazo OL, White PF. Figure 3 Summary of factors guiding strategic opioid use for the management of acute pain in surgical patients. Multifaceted strategies that include modified pre-, intra-, and postoperative practices may also support reduced reliance on perioperative opioids. 
